Profilo
Mr. John Ruesch is a Chief Technical Operations Officer at BioCryst Pharmaceuticals, Inc. Mr. Ruesch was previously employed as a SVP-Pharmaceutical Sciences & Technical Operations by Astria Therapeutics, Inc., a Vice President-Pharmaceutical Development by Surface Oncology, Inc., and a Senior Director-Drug Product Development by Biogen, Inc. He received his undergraduate degree from Valparaiso University and an MBA from Kellogg School of Management.
Posizioni attive di John Ruesch
| Società | Posizione | Inizio |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/01/2026 |
Precedenti posizioni note di John Ruesch
| Società | Posizione | Fine |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2025 |
| SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | 01/01/2023 |
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2021 |
Formazione di John Ruesch
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Valparaiso University
Valparaiso University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
















